Stopping vomiting in dialysis patients usually requires identifying the specific trigger rather than simply reaching for an anti-nausea pill. Nausea affects roughly a third of people with end-stage kidney disease, and vomiting follows in a meaningful fraction of those cases. The causes range from blood-pressure drops during the treatment itself to medication side effects, sluggish stomach emptying, and residual uremic toxins that accumulate between sessions. Because these triggers overlap and interact, effective management typically combines adjustments to the dialysis prescription, careful medication choices, and sometimes surprisingly simple changes like eating differently or lowering the temperature of the dialysate fluid.
Why Dialysis Patients Vomit So Often
Nausea and vomiting are among the most common complaints in people on dialysis, yet they tend to get less clinical attention than problems like anemia or bone disease. A systematic review of symptom prevalence in end-stage kidney disease found a weighted mean nausea prevalence of about 33%, with individual studies reporting rates anywhere from 15% to 48%.1Advances in Chronic Kidney Disease. The Prevalence of Symptoms in End-Stage Renal Disease: A Systematic Review One study of hemodialysis patients put the incidence of nausea during treatment at roughly 28% and vomiting at about 12%.2PubMed Central. Incidence and severity of nausea and vomiting in a group of maintenance hemodialysis patients A separate systematic review of gastrointestinal symptoms in dialysis patients noted that while these problems are highly prevalent, the evidence base for treatments remains limited and researchers are still sorting out which causes are preventable.3PubMed. Gastrointestinal symptoms in patients receiving dialysis: A systematic review
The causes of vomiting in this population fall into a few broad categories, and pinpointing which one is responsible in a given patient is the first step toward fixing it.
Blood Pressure Drops During Treatment
The single most common acute trigger for nausea and vomiting during a hemodialysis session is intradialytic hypotension, a sudden drop in blood pressure that happens when fluid is removed faster than the body can compensate. During dialysis, the machine pulls excess fluid from the blood through a process called ultrafiltration. When the rate of fluid removal outpaces the body’s ability to shift fluid from tissues back into the bloodstream, blood volume falls, blood pressure crashes, and the patient feels dizzy, nauseated, or begins vomiting. The heart rate and blood vessels are supposed to compensate by speeding up and tightening, but in many dialysis patients those reflexes are blunted by age, diabetes, or medications.4Clinical Kidney Journal. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management
This means anything that increases the volume of fluid needing removal, like drinking more between sessions or gaining more weight between treatments, raises the odds of a blood-pressure crash and the nausea that goes with it. Patients who can limit interdialytic fluid gains are less likely to need aggressive ultrafiltration and therefore less likely to feel sick during sessions.
Dialysis Disequilibrium Syndrome
A less common but more alarming cause of vomiting during or right after treatment is dialysis disequilibrium syndrome. This happens when urea and other waste products are cleared from the blood faster than they leave the brain, creating a temporary osmotic imbalance. Water follows the higher concentration of solutes in brain tissue, causing mild swelling. The result is headache, nausea, vomiting, muscle cramps, and in severe cases, tremors or altered consciousness.5PubMed. Dialysis disequilibrium syndrome: a narrative review Disequilibrium syndrome is most common in patients just starting dialysis, particularly when their first sessions are run at high efficiency. It can be prevented by starting new patients with shorter, gentler sessions and gradually increasing the intensity over the first few treatments.
Tweaking the Dialysis Machine
Several adjustments to the dialysis prescription itself can reduce nausea and vomiting, sometimes dramatically.
Cooler Dialysate
Standard dialysate is warmed to body temperature, but lowering it slightly, typically to around 35–36°C instead of 37°C, triggers mild vasoconstriction that helps maintain blood pressure. A review of the evidence found that cooled dialysate improves hemodynamic stability during and after treatment, even in patients prone to blood-pressure drops, without hurting dialysis adequacy.6PubMed Central. Cooling dialysate during in-center hemodialysis: Beneficial and deleterious effects Research has also found that combining cool dialysate with sodium and ultrafiltration profiling reduces the incidence of hypotension and associated symptoms like nausea and vomiting more than any single method alone.7PubMed Central. The effect of hemodialysis with cool dialysate on nausea in hemodialysis patients: A randomized clinical trial The main tradeoff is that some patients feel uncomfortably cold or develop shivering. Adjusting the temperature incrementally and providing blankets usually solves this.
Ultrafiltration and Sodium Profiling
Rather than removing fluid at a constant rate throughout the session, ultrafiltration profiling varies the rate, typically starting with faster removal while the patient’s blood volume is highest and tapering as the session goes on. A study comparing different profiling strategies found that a continuously decreasing ultrafiltration rate cut symptomatic hypotension episodes to about 6% of treatments, compared with roughly 11% with a constant rate. Profiles that used intermittent high-rate pulses actually made things worse, bumping symptomatic episodes up to about 18%.8American Journal of Kidney Diseases. Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects
Sodium profiling works on a similar principle. Starting the session with a slightly higher dialysate sodium concentration slows osmotic fluid shifts early on, then reducing it over the course of the treatment allows the extra sodium to be cleared by session’s end. In a randomized trial, combining sodium and ultrafiltration profiling dropped the proportion of symptomatic sessions from about 31% to about 20%, a reduction of roughly a third.9Journal of the American Society of Nephrology. Impact of Sodium and Ultrafiltration Profiling on Hemodialysis-Related Symptoms The concern with sodium profiling is that if the extra sodium is not fully cleared, patients may feel thirstier between sessions, drink more, and come in with more fluid to remove next time, potentially negating the benefit.
Anti-Nausea Medications and Their Cardiac Risks
When machine adjustments alone do not control vomiting, anti-nausea drugs become necessary. The two most commonly prescribed in this population are ondansetron and metoclopramide, but both carry risks that are amplified by kidney failure.
Ondansetron is widely used and effective, but it can affect the heart’s electrical conduction. A large study of over 119,000 hemodialysis patients found that those who started ondansetron had a higher risk of sudden cardiac death over the following ten days compared with those started on a different antiemetic, with a roughly 44% increase in relative risk. In absolute terms, the excess risk was small: about 1 additional sudden cardiac death for every 1,688 patients treated.10PubMed Central. Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis That sounds rare, but dialysis patients already have elevated cardiac risk, so the finding has prompted some clinicians to use ondansetron more selectively and at the lowest effective dose. A smaller emergency department study of dialysis patients who already had prolonged QTc intervals found that giving antiemetics did not measurably worsen their heart rhythm on average, and no patients in that study had life-threatening arrhythmias.11The Journal of Emergency Medicine. The Effect of Antiemetics and Antihistamines on the QTc Interval in Emergent Dialysis Patients With Baseline QTc Prolongation The evidence is not entirely settled, but caution with ondansetron seems reasonable, especially in patients who already have heart rhythm abnormalities.
Metoclopramide is the other frequently used option. It works differently, promoting stomach emptying as well as blocking nausea signals. However, regulatory agencies in both North America and Europe have tightened restrictions on it because of the risk of neurological side effects, including involuntary movements that can become permanent with prolonged use.12PubMed Central. Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients? For dialysis patients, who often need anti-nausea treatment repeatedly over months and years, this is a real concern. Guidelines generally recommend limiting metoclopramide to short courses.
When nausea is tied to gastroparesis, a condition common in diabetic dialysis patients, prokinetic agents like domperidone can help move food through the stomach. Domperidone has a lower risk of crossing into the brain and causing the neurological problems seen with metoclopramide, though it carries its own cardiac warnings. European guidelines suggest antiemetics should be used cautiously in kidney failure, since impaired clearance can intensify side effects.13Archives of Clinical and Experimental Pathology. Navigating Post-Dialysis Challenges: A Review of Common Symptomatology and Clinical Management Approaches
Gastroparesis and Dietary Changes
A substantial number of dialysis patients, particularly those with long-standing diabetes, have gastroparesis: the stomach empties abnormally slowly because the nerves controlling its muscles have been damaged. Food sits in the stomach for hours, causing fullness, bloating, nausea, and vomiting. In a pair of case reports involving diabetic dialysis patients with confirmed gastroparesis, dietary modifications alone resolved the nausea and vomiting even though the underlying delayed emptying did not improve on imaging. The approach centered on eating smaller, more frequent meals, favoring softer or liquid-consistency foods, and avoiding high-fat or high-fiber items that slow emptying further.14Renal Replacement Therapy. Dietary modifications achieved successful resolution of symptoms of gastroparesis diagnosed by demonstrating gastric food retention after overnight fasting in diabetic dialysis patients: two case reports with literature review
For patients who vomit during sessions specifically, meal timing matters. Eating a large meal right before dialysis fills the stomach at the worst possible moment, because blood is diverted away from the gut during treatment. Many nephrologists advise having a light snack rather than a full meal before the session, and eating the day’s main meal afterward.
Medications That Cause Nausea as a Side Effect
Dialysis patients take a lot of pills, and some of them are notorious for causing nausea and vomiting. Cinacalcet, used to control overactive parathyroid glands (a common complication of kidney failure), is one of the worst offenders. Tolerance of cinacalcet is limited by frequent gastrointestinal side effects including nausea and vomiting, along with drops in calcium levels.15PubMed Central. Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism Taking it with food and starting at a low dose with gradual increases can help, but some patients simply cannot tolerate it. Phosphate binders, iron supplements, and certain antibiotics are other common culprits. When a patient’s nausea pattern coincides with starting or increasing one of these medications, the connection is often straightforward, and switching formulations or adjusting timing may resolve the problem without adding an antiemetic.
Allergic Reactions to Dialysis Equipment
An uncommon but important cause of nausea and vomiting during hemodialysis is a hypersensitivity reaction to the dialysis membrane or sterilizing agents used in the dialyzer. Older cuprophane membranes were particularly prone to triggering complement activation, a cascade of immune proteins, within minutes of blood contacting the membrane. In early research on this phenomenon, patients with severe reactions showed massive complement activation within ten minutes of starting dialysis, with symptoms including chest pain, shortness of breath, low blood pressure, and nausea.16PubMed. Complement activation and hypersensitivity reactions to dialysis membranes Modern synthetic membranes are far more biocompatible, but reactions still occasionally occur, sometimes to the membrane material itself and sometimes to residual sterilant like ethylene oxide.17PubMed Central. Allergic reaction to polysulphone membrane dialyser masquerading as infection If nausea and vomiting consistently start within the first 15–30 minutes of a session and are accompanied by flushing, itching, or breathing difficulties, a membrane reaction should be suspected. Switching to a different membrane type or sterilization method typically resolves it.
Peritoneal Dialysis and Gut Symptoms
Patients on peritoneal dialysis, which uses the lining of the abdomen rather than a machine to filter blood, have their own set of gastrointestinal struggles. A study of peritoneal dialysis patients found that over 82% reported at least one GI symptom, with higher rates linked to depression, lower blood pressure, lower urine output, and a greater daily pill burden.18BMC Nephrology. Patient-reported gastrointestinal symptoms in patients with peritoneal dialysis: the prevalence, influence factors and association with quality of life The fluid sitting in the abdominal cavity can itself cause fullness and nausea by physically compressing the stomach, especially after a fresh fill. Strategies include using smaller fill volumes, adjusting the dwell schedule so the abdomen is emptied around mealtimes, and treating depression and gastroparesis if present.
Ruling Out Underlying Stomach Problems
Because dialysis patients are prone to nausea for so many reasons, it is easy to overlook a separate gastrointestinal condition causing or worsening symptoms. Gastritis, peptic ulcers, and reflux disease are all common in this population, partly because kidney failure alters stomach acid production and mucosal defenses. Helicobacter pylori, the bacterium behind many ulcers, is sometimes suspected as a driver, but a meta-analysis found no difference in H. pylori prevalence between dialysis patients and people with normal kidney function. Interestingly, patients who had been on dialysis for more than four years had significantly lower rates of H. pylori infection than the general population.19PubMed Central. Helicobacter pylori Infection in Dialysis Patients: A Meta-Analysis This means H. pylori is not a uniquely elevated concern in dialysis patients, but it should not be ignored either, especially in newer patients who have not yet been on treatment long enough for rates to decline. A simple breath or stool test can identify it, and standard eradication therapy works in most cases.
Non-Drug Approaches
Given the cardiac and neurological risks of the available antiemetics, non-drug strategies are worth exploring. Acupressure, particularly at the P6 (inner wrist) point traditionally used for motion sickness, has been studied in dialysis patients. A systematic review of the available randomized trials found that acupressure was not clearly superior to sham acupressure or electrical stimulation, though a few studies suggested benefits compared with usual care alone. Importantly, no adverse events were reported across the trials.20Mary Ann Liebert, Inc. / PubMed Central. Role of acupressure in symptom management in patients with end-stage renal disease: a systematic review The evidence is thin enough that acupressure should not replace proven strategies, but it is essentially harmless and some patients find it helpful, particularly when nausea is mild or when medications are being avoided.
Other practical measures that clinicians recommend based on experience rather than large trials include ginger tea or ginger chews during sessions, keeping the head slightly elevated during treatment, avoiding strong odors in the dialysis unit, and distraction techniques like conversation, music, or television. These are low-cost and risk-free, and while they are unlikely to control severe vomiting on their own, they can make a meaningful difference for patients with milder symptoms.
Uremic Toxins and Whether Dialysis Is Adequate
Sometimes the nausea and vomiting are themselves a signal that dialysis is not doing enough. When treatments are too short, too infrequent, or delivered through a poorly functioning vascular access, uremic toxins build up between sessions and provoke nausea in the hours before the next treatment. If a patient consistently feels sickest in the day or two before their next session, inadequate clearance is a strong possibility. Checking the delivered dialysis dose and ensuring the vascular access is functioning properly are essential steps. Adjusting the dialysate composition to better match the patient’s electrolyte needs can also help when nausea is tied to electrolyte shifts during treatment.13Archives of Clinical and Experimental Pathology. Navigating Post-Dialysis Challenges: A Review of Common Symptomatology and Clinical Management Approaches In some patients, increasing dialysis frequency from three times a week to daily short sessions or long nocturnal sessions substantially reduces nausea by preventing the dramatic peaks and valleys in toxin levels that conventional schedules create.
Gut-derived uremic toxins like indoxyl sulfate and trimethylamine N-oxide (TMAO) are increasingly recognized as contributors to symptoms and overall inflammation in kidney disease. Preliminary research on Chinese herbal enema preparations found reductions in some of these toxins in pre-dialysis chronic kidney disease patients.21PubMed Central. Effect of Chinese herbal enema prescription on renal function, enterogenous uremic toxins and intestinal barrier function in stage 3 to 5 chronic kidney disease predialysis participants: A randomized controlled trial Whether targeting these specific toxins translates into less nausea for people already on dialysis is still an open question, but it is an active area of research and hints at future strategies beyond simply increasing the volume of fluid filtered.